CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 367 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03682757
NCT03682757N/ACompleted

Post-Injury Platelet Biology: Mechanisms and Outcomes

University of California, San Francisco·observational·Posted Sep 25, 2018·Updated Dec 8, 2023

In Brief

An observational study for Wound and Injuries and 2 related conditions. Completed, enrolled 367 participants across 1 site.

Detailed Summary

Trauma-induced coagulopathy is a central cause of preventable deaths from hemorrhage after injury. The contribution and impact of altered post injury platelet biology on trauma-induced coagulopathy is not well understood despite the pivotal contribution of platelets to normal coagulation and endothelial integrity. The central hypothesis for this study is that severe injury and shock drive altered platelet activation, platelet aggregation, and platelet-endothelial interactions that are associated with increased rates of transfusion, organ failure, and mortality. This study will investigate these causal pathways, mechanisms, and associated outcomes in a prospective observational trauma cohort through collection of biospecimens and detailed clinical data.

Study Details

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 25, 2018
Enrollment StartSep 20, 2018
Primary CompletionSep 30, 2023
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 7.8 years ago